Auditory function after application of ototopical vancomycin and mupirocin solutions in a murine model

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 3, 2011, Pages 419-426

  Rutherford, Kimberley D ^a   Kavanagh, Katherine ^b   Parham, Kourosh ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Division of Pediatric Infectious Diseases   (United States)

Author keywords

Auditory brainstem response; Mupirocin; Ototoxicity; Vancomycin

Indexed keywords

PSEUDOMONIC ACID; SODIUM CHLORIDE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EARDRUM; EARDRUM PERFORATION; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GRANULATION TISSUE; HEARING; INJECTION SITE; MOUSE; NONHUMAN; OTOTOXICITY; TREATMENT OUTCOME; ANIMAL; CBA MOUSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; INTRALESIONAL DRUG ADMINISTRATION; OTITIS MEDIA;

ANIMALS; ANTI-BACTERIAL AGENTS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GRANULATION TISSUE; INJECTIONS, INTRALESIONAL; MICE; MICE, INBRED CBA; MUPIROCIN; OTITIS MEDIA; VANCOMYCIN;

EID: 79959780525     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810392315     Document Type: Article

References (21)

1. Hannley MT, Denneny JC, Holzer SS. Use of ototopical antibiotics in treating three common ear diseases. Otolaryngol Head Neck Surg. 2000;122:934-940. (Pubitemid 30412671)
2. Roland PS, Parry DA, Stroman DW. Microbiology of acute otitis media with tympanostomy tubes. Otolaryngol Head Neck Surg. 2005;133:585-595. (Pubitemid 41431850)
3. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalence of bacteria and viruses. Clin Infect Dis. 2006;43:1417-1422. (Pubitemid 44845642)
4. Hwang JH, Tsai HY, Liu TC. Community-acquired methicillin-resistant Staphylococcus aureus infections in discharging ears. Acta Otolaryngol. 2002;122:827-830.
5. Choi HG, Park KH, Park SN, et al. The appropriate medical management of methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media. Acta Otolaryngol. 2010;130:42-46.
6. Moo KP, Myung HJ, Hee JK, et al. The changes of MRSA infections in chronic suppurative otitis media. Otolaryngol Head Neck Surg. 2008;139:395-398.
7. Jang CH, Chang-Hun S, Pa-Chun W. Topical vancomycin for chronic suppurative otitis media with methicillin-resistant Staphylococcus aureus otorrhea. J Laryngol Otol. 2004;118:645-647.
8. MacNeil SD, Westerburg BD, Romney MG. Toward the development of evidence based guidelines for the management of methicillin-resistant Staphylococcus aureus otitis. J Otolaryngol Head Neck Surg. 2009;38:483-494.
9. Haynes DS, Rutka J, Hawke M, et al. Ototoxicity of ototopical drops: an update. Otolaryngol Clin North Am. 2007;40:669-683.
10. Roland PS, Stewart MG, Hannley M, et al. Consensus panel on the role of potentially ototoxic antibiotics for middle ear use: introduction, methodology, and recommendations. Otolaryngol Head Neck Surg. 2004;130(suppl):S51-S56. (Pubitemid 38445573)
11. Berndtson WE. A simple, rapid and reliable method for selecting or assessing the number of replicates for animal experiments. J Anim Sci. 1991;69:67-76.
12. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother. 1985;27:495-498. (Pubitemid 15097646)
13. McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 2009;29:263-280.
14. GlaxoSmithKline. www.gsk.com/products/prescription-medicines/ us/bactroban-us.htm. Accessed June 1, 2009.
15. Uren B, Psaltis A, Wormald PJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope. 2008;118:1677-1680.
16. Solares CA, Batra PS, Hall GS, Citardi MJ. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol. 2006;27:161-165.
17. Furukuwa M, Minekawa A, Haruyama T, et al. Clinical effectiveness of ototopical application of mupirocin ointment in methicillin-resistant Staphylococcus otorrhea. Otol Neurootol. 2008;29:676-678.
18. Forouzesh A, Moise PA, Sakoulas G. Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother. 2009;53:483-486.
19. Roehm P, Hoffer M, Balaban CD. Gentamicin uptake in the chinchilla inner ear. Hear Res. 2007;230:43-52. (Pubitemid 47058837)
20. Blakely BW, Hochman J, Wellman M, Gooi A, Hussain AE. Differences in ototoxicity across species. J Otolaryngol Head Neck Surg. 2008;37:700-703.
21. Poirrier AL, Van den Ackerveken P, Kim TS, et al. Ototoxic drugs: difference in sensitivity between mice and guinea pigs. Toxicol Lett. 2010;193:41-49.